Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclerion Therapeutics, Inc.

3.04
+0.12174.17%
Post-market: 3.040.00000.00%17:15 EDT
Volume:7.03K
Turnover:21.01K
Market Cap:9.76M
PE:-2.62
High:3.10
Open:2.90
Low:2.90
Close:2.92
Loading ...
Mar 19, 2021

Major Issues Report

8-K/A [Amend] - Current report
Mar 18, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2021

Major Issues Report

8-K - Current report
Dec 21, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 14, 2020

Major Issues Report

8-K - Current report
Oct 01, 2020

Major Issues Report

8-K - Current report
Sep 22, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 09, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 03, 2020

Major Issues Report

8-K - Current report
Aug 12, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 03, 2020

Major Issues Report

8-K - Current report
Aug 03, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2020

Correspondence

CORRESP [Cover] - Correspondence